Jiangsu Recbio Shoots To Become Hong Kong's First HPV Vaccine Stock
Key takeaways:
Jiangsu Recbio has filed a second IPO application to list in Hong Kong, hoping to become the first HPV vaccine maker in the market
The company was valued at around 9 billion yuan after its latest funding round
By Molly Wen
